SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

COP is trending due to options activity and discussions around its resilience amid fluctuating oil prices, with community members weighing bullish and bearish sentiments. Some analysts are adjusting price targets, while others highlight the potential benefits of the Marathon Oil acquisition and LNG deals. Discussions also revolve around the company's dividend policy and potential for long-term profitability in a volatile energy sector.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Niagen Bioscience ($NAGE) is trending as the community discusses recent gains and upcoming catalysts, with a focus on clinical trial results and their potential impact. Discussions include institutional ownership, short interest, and the company's new patent. Optimism surrounds potential partnerships and broader market recognition of Niagen's value proposition in cellular health and longevity.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is trending as holders observe substantial transfer increases, sparking discussions around potential catalysts and future price movement. The community is analyzing chart patterns and on-chain metrics, while also speculating on possible connections to spiritual meanings and upcoming events like "Uptober". Despite some skepticism, many express long-term bullish sentiment, citing the fully diluted coin supply and anticipation of wider crypto adoption.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax ($NVAX) is trending as discussions revolve around Sanofi's marketing of Nuvaxovid and its potential impact on market share, especially with concerns raised about mRNA vaccines. The community is actively debating the company's future prospects, potential partnerships for its Combination Influenza/Covid (CIC) vaccine, and what it means for revenue. Some traders anticipate a possible gamma squeeze.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending due to a strong earnings report and raised guidance, sparking optimism about its growth prospects in innovative medicine and medtech. Bullish sentiment is further fueled by analyst upgrades and a potential breakout from a multi-year base, while some traders are closely monitoring potential impacts from ongoing talc litigation and looming pharma tariffs.

MYX Finance

MYX.X is seeing increased volatility and trending as traders discuss potential bullish reversals and shorting opportunities. Community members are actively speculating on price targets and comparing MYX Finance to other altcoins and DEX platforms, particularly those backed by major players like Coinbase and Binance. The conversation also includes discussions about token unlocks and their potential impact on price.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending due to unusual options activity and discussions around its long-term potential, particularly its free cash flow and dividend growth prospects. The community is weighing bullish call option flows against concerns about collapsing free cash flow and high payout ratios, while analyzing the impact of the company's ongoing capital expenditure buildout. Some anticipate significant boosts to free cash flow and dividend growth in 2026 if management's long-term bets pay off.

Comfort Systems USA, Inc. engages in the provision of mechanical and electrical contracting services. It operates through the following segments: Mechanical, Electrical Services, and Corporate. The Mechanical Services segment includes heating, ventilation, and air conditioning, plumbing, piping, and controls, as well as off-site construction, monitoring, and fire protection. The Electrical services segment focuses on installation and servicing of electrical systems. The company was founded by Alfred J. Giardinelli, Jr. And William George III on December 12, 1996 and is headquartered in Houston, TX.

Comfort Systems USA, Inc.

Comfort Systems USA ($FIX) is trending as investors weigh the company's potential in the AI-driven data center boom and industrial expansion, with some calling it a hidden gem in its sector. The community is actively discussing the company's record backlog and comparing it to competitors, while also speculating on a potential stock split. Strong Q2 results, margin expansion, and institutional demand are contributing to the bullish sentiment around this old-economy stock.

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Cencora Inc.

Cencora Inc. is trending due to a combination of factors, including positive momentum in the healthcare REIT sector and strong growth prospects within the pharmaceutical distribution industry. Unusual options activity and analyst target price adjustments are contributing to the increased attention. Community members are also discussing potential impacts from international supply chain dynamics and the company's expansion into specialty markets.

The Bank of New York Mellon Corp. is a holding company, which engages in the provision of financial services. It operates through the following segments: Securities Services, Market and Wealth Services, Investment and Wealth Management, and Other. The Securities Services segment includes the Asset Servicing business, which provides global custody, fund accounting, integrated middle-office solutions, transfer agency and data, and analytics solutions. The Market and Wealth Services segment consists of the Pershing, Clearance and Collateral Management, and Treasury Services businesses. The Investment and Wealth Management segment is involved in services to institutional and retail investors, as well as investment management, wealth, and estate planning. The Other segment refers to the leasing portfolio, corporate treasury activities, derivatives, and other trading activity. The company was founded by Alexander Hamilton on June 9, 1784 and is headquartered in New York, NY.

Bank Of New York Mellon Corp

Bank of New York Mellon ($BK) is trending due to a combination of factors including strong quarterly earnings, a recent dividend increase, and analyst upgrades, sparking community discussion around its growth potential. The Fed's rate cut has further fueled optimism for national bank stocks like $BK, with potential upside from domestic lending and digital adoption trends. Additionally, speculation around potential takeovers and partnerships in the crypto space is adding to the stock's current buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Abiomed Inc.

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$381.02
Prev Close	$380.79
Open	$380.78
Dividend Yield	N/A
50-Day Moving Average	$343.62
Beta	0.83
Avg. Volume	2.01M
PE Ratio	65.48

52-Week High	$381.99
52-Week Low	$219.85
Market Capitalization	$17.18B
EPS (Annual)	N/A
Price to Book	11.18
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ABMD
Abiomed Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest ABMD News

ABMD Abiomed Inc.